Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9017825 | Toxicology and Applied Pharmacology | 2005 | 11 Pages |
Abstract
This neurobehavioral test battery clearly detected neurological activity and defined time-course characteristics after treatment with EMD 96785 or EMD 125021. The various clinical parameters were grouped into functional-related domains and most alterations were seen in the domains of central nervous system and neuromuscular system. The most prominent clinical findings were seen with the pharmacologically more potent NHE inhibitor EMD 125021 when compared to EMD 96785. The clinical symptoms were proven to be reversible by 7 days after the single treatment for both compounds.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Nicole Hübler, Barbara Gottschling, Maren Jacobs, Friedrich von Landenberg, Marion Hewicker-Trautwein,